← All organizations

Bristol-Myers

For profitContributed to NME

Also known as: BRISTOL | Bristol Myers | BRISTOL-MYERS

Highest phase reached

Phase 1

First clinical trial

Oct 1, 2007

First marketed drug

Feb 20, 1945

First NDA

Feb 20, 1945

Last known activity

Oct 1, 2007

Acquired by Bristol-Myers Squibb on Jan 1, 1989

Timeline

1880s

  1. Jan 1, 1887

    Bristol-Myers— Founded

1940s

  1. Jan 1, 1943

    Cheplin Laboratories— Acquired

1960s

  1. Jan 1, 1968

    Mead Johnson— Acquired

1970s

  1. Aug 3, 1973

    cholestyramine— NDA Organization

1980s

  1. Jan 1, 1989

    Bristol-Myers Squibb— Acquired By

2010s

  1. Jan 29, 2015

    atazanavir— NDA Secondary Org

  2. Aug 16, 2019

    fedratinib— Marketing Organization

Drugs by trial phase (20 distinct, 34 trials)

Phase 4 (0 own, 2 via acquisition)

Phase 3 (0 own, 3 via acquisition)

Phase 2 (0 own, 2 via acquisition)

Phase 1 (1 own, 2 via acquisition)

Indications

Studied for

Marketed drugs (48)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (1)

Details

Founded
Clinton, NY, US Jan 1, 1887
First NDA
Feb 20, 1945
Last known activity
Oct 1, 2007

Designations held

  • Priority review